NCT06127121 A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients
| NCT ID | NCT06127121 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-11-02 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2023-11-02 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To look at how a digital art activity may help cancer patients improve their ability to express their distress, symptoms, and lived experience.
Eligibility Criteria
Inclusion Criteria: 1. Age equal or greater than 18 years 2. Patients who are admitted in the hospital and have received a cancer diagnosis. 3. Suffering from solid cancer or hematological malignancy and receiving active treatment for their cancer. 4. Voluntary written consent. 5. Fluent in English or Spanish. Exclusion Criteria: 1. Not being able to use a digital tablet 2. Being speech impaired or vision impaired 3. Patients who are cognitively impaired and unable to read or consent for the study 4. Pregnant women
Contact & Investigator
Carlos Roldan, MD
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06127121 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06127121 currently recruiting?
Yes, NCT06127121 is actively recruiting participants. Contact the research team at croldan@mdanderson.org for enrollment information.
Where is the NCT06127121 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06127121 clinical trial?
NCT06127121 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Carlos Roldan, MD at M.D. Anderson Cancer Center. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.